Literature DB >> 6087796

Characterization of the homologous and heterologous desensitization of rat Leydig-tumour-cell adenylate cyclase.

C J Dix, A D Habberfield, B A Cooke.   

Abstract

The homologous and heterologous desensitization of rat Leydig-tumour-cell adenylate cyclase induced by lutropin (LH) was characterized with the aid of forskolin and cholera toxin. Forskolin stimulated cyclic AMP production in a dose-dependent manner, with linear kinetics up to 2h. Forskolin also potentiated the action of LH on cyclic AMP production, but was only additive with cholera toxin. Preincubation of rat Leydig tumour cells with LH (1.0 micrograms/ml) for 1 h produced a desensitization of the subsequent LH (1.0 micrograms/ml)-stimulated cyclic AMP production, whereas the responses to cholera toxin (5.0 micrograms/ml), forskolin (100 microM), LH plus forskolin or cholera toxin plus forskolin were unaltered. In contrast, preincubation with LH for 20h produced a desensitization to all the stimuli tested. When rat Leydig tumour cells were preincubated for 1h with forskolin or dibutyryl cyclic AMP, the only subsequent response that was significantly altered was that to LH plus forskolin after preincubation with forskolin. However, preincubation for 20h with forskolin or dibutyryl cyclic AMP induced a desensitization to all stimuli subsequently tested. LH produced a rapid (0-1h) homologous desensitization, which was followed by a slower (2-8h)-onset heterologous desensitization. Forskolin and dibutyryl cyclic AMP were only able to induce heterologous desensitization. The rate of desensitization induced by either forskolin or dibutyryl cyclic AMP was similar to the rate of heterologous desensitization induced by LH. These results demonstrate that in purified rat Leydig tumour cells LH produces an initial homologous desensitization of adenylate cyclase that involves a cyclic AMP-independent lesion at or proximal to the guanine nucleotide regulatory protein (G-protein). This is followed by heterologous desensitization, which can also be induced by forskolin or dibutyryl cyclic AMP, thus indicating that LH-induced heterologous desensitization of rat Leydig-tumour-cell adenylate cyclase involves a cyclic AMP-dependent lesion that is after the G-protein.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6087796      PMCID: PMC1153699          DOI: 10.1042/bj2200803

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  28 in total

1.  Resolution of some components of adenylate cyclase necessary for catalytic activity.

Authors:  E M Ross; A G Gilman
Journal:  J Biol Chem       Date:  1977-10-25       Impact factor: 5.157

2.  Radioimmunoassay for cyclic nucleotides. I. Preparation of antibodies and iodinated cyclic nucleotides.

Authors:  A L Steiner; C W Parker; D M Kipnis
Journal:  J Biol Chem       Date:  1972-02-25       Impact factor: 5.157

3.  The role of hormone receptors and GTP-regulatory proteins in membrane transduction.

Authors:  M Rodbell
Journal:  Nature       Date:  1980-03-06       Impact factor: 49.962

4.  Catecholamine-specific desensitization of adenylate cyclase. Evidence for a multistep process.

Authors:  Y F Su; T K Harden; J P Perkins
Journal:  J Biol Chem       Date:  1980-08-10       Impact factor: 5.157

5.  Mechanism of desensitization of adenylate cyclase in lutropin. GTP-dependent uncoupling of the receptor.

Authors:  E Ezra; Y Salomon
Journal:  J Biol Chem       Date:  1980-01-25       Impact factor: 5.157

6.  Resensitization of the desensitized follicular adenylyl cyclase system to luteinizing hormone.

Authors:  M Hunzicker-Dunn; D Derda; R A Jungmann; L Birnbaumer
Journal:  Endocrinology       Date:  1979-06       Impact factor: 4.736

7.  A Leydig cell tumour: a model for the study of lutropin action.

Authors:  B A Cooke; L M Lindh; F H Janszen; M J van Driel; C P Bakker; M P van der Plank; H J van der Molen
Journal:  Biochim Biophys Acta       Date:  1979-03-22

8.  Challenge of hepatocytes by glucagon triggers a rapid modulation of adenylate cyclase activity in isolated membranes.

Authors:  C M Heyworth; M D Houslay
Journal:  Biochem J       Date:  1983-07-15       Impact factor: 3.857

9.  Use of cell fusion techniques to probe the mechanism of catecholamine-induced desensitization of adenylate cyclase in frog erythrocytes.

Authors:  L J Pike; R J Lefkowitz
Journal:  Biochim Biophys Acta       Date:  1980-10-15

10.  Activation of renal adenylate cyclase by forskolin: assessment of enzymatic activity in animal models of the secondary hyperparathyroid state.

Authors:  L R Forte
Journal:  Arch Biochem Biophys       Date:  1983-09       Impact factor: 4.013

View more
  5 in total

1.  Similarities and differences in phorbol ester- and luteinizing-hormone-induced desensitization of rat tumour Leydig-cell adenylate cyclase.

Authors:  C J Dix; A D Habberfield; B A Cooke
Journal:  Biochem J       Date:  1987-04-15       Impact factor: 3.857

2.  Forskolin refractoriness. Exposure to the diterpene alters guanine nucleotide-dependent adenylate cyclase and calcium-uptake activity of cells cultured from the rat aorta.

Authors:  J F Krall; N Jamgotchian
Journal:  Biochem J       Date:  1987-01-15       Impact factor: 3.857

3.  Control and production of leukotriene B4 in rat tumour and testicular Leydig cells.

Authors:  M H Sullivan; B A Cooke
Journal:  Biochem J       Date:  1985-09-15       Impact factor: 3.857

4.  The inhibitory GTP-binding protein (Gi) occurs in rat Leydig cells and is differentially modified by lutropin and 12-O-tetradecanoylphorbol 13-acetate.

Authors:  E A Platts; D Schulster; B A Cooke
Journal:  Biochem J       Date:  1988-08-01       Impact factor: 3.857

5.  Adenosine potentiates lutropin-stimulated cyclic AMP production and inhibits lutropin-induced desensitization of adenylate cyclase in rat Leydig tumour cells.

Authors:  C J Dix; A D Habberfield; B A Cooke
Journal:  Biochem J       Date:  1985-08-15       Impact factor: 3.857

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.